 |
Dorset |
 |
The Dorset Formulary has been developed in associations with
NHS Dorset Clinical Commissioning Group
Dorset County Hospital NHS Foundation Trust
Dorset Healthcare University NHS Foundation Trust
Poole Hospital NHS Foundation Trust
Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust |
|
| Formulary Chapter 5: Infections - Full Section
|
Notes:
Chapter review date: |
| Useful Links |
 SCAN Guidelines for antibiotic prescribing in the community 2018 |
|
NICE NG120: Cough (acute): antimicrobial prescribing (February 2019) |
|
NICE guideline NG114: Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing (December 2018) |
|
NICE NG117: Bronchiectasis (acute exacerbation): antimicrobial prescribing (December 2018) |
|
NICE NG112: Urinary tract infection (recurrent): antimicrobial prescribing (October 2018) |
|
NICE NG110: Prostatitis (acute): antimicrobial prescribing (October 2018) |
|
NICE NG111: Pyelonephritis (acute): antimicrobial prescribing (October 2018) |
|
NICE NG109: Urinary tract infection (lower): antimicrobial prescribing (October 2018) |
|
NICE NG95: Lyme Disease (April 2018) |
|
NICE NG91 Otitis media (acute): antimicrobial prescribing (March 2018) |
|
NICE NG84 Sore throat (acute): antimicrobial prescribing (January 2018) |
|
NICE NG79 Sinusitis (acute): antimicrobial prescribing (October 2017) |
|
BHIVA Guidelines |
|
Dental Letter Infective Endocarditis March 2019 |
 Dorset Guidance:Antibiotic Prophylaxis (AP) prior to Dental Treatment to prevent Infective Endocarditis March 2019 |
|
SDCEP Antibiotic Prophylaxis Against Infective Endocarditis |
|
DCHFT: Adult Surgical Antibiotic Treatment Guidelines |
|
DCHFT: IV antibiotic to oral switch guidelines |
|
DCHFT: Medical Directorate Antibiotic Treatment Guidelines |
|
DCHFT: Antibiotic stop / review date and indication policy |
|
DCHFT: Penicillin allergy ’traffic light’ guideline |
| Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
|
|
05.01 |
Antibacterial drugs
(1,0)
|
|
|
Table 1. Summary of antibacterial therapy
(0,0)
|
|
|
Table 2. Summary of antibacterial prophylaxis
(0,0)
|
|
05.01.01 |
Penicillins
(0,0)
|
|
05.01.01.01 |
Benzylpenicillin and phenoxymethylpenicillin
(4,0)
|
|
05.01.01.02 |
Penicillinase-resistant penicillins
(3,0)
|
|
05.01.01.03 |
Broad-spectrum penicillins
(4,2)
|
|
05.01.01.04 |
Antipseudomonal penicillins
(1,1)
|
|
05.01.01.05 |
Mecillinams
(0,0)
|
|
05.01.02 |
Cephalosporins, carbapenems and other beta-lactums
(0,0)
|
|
|
Cephalosporins
(0,0)
|
|
|
Other beta-lactam antibiotics
(0,1)
|
|
05.01.02.01 |
Cephalosporins
(8,5)
|
|
05.01.02.02 |
Carbapenems
(3,0)
|
|
05.01.02.03 |
Other beta-lactums antibiotics
(2,0)
|
|
05.01.03 |
Tetracyclines
(3,3)
|
|
|
Tigecycline
(1,0)
|
|
05.01.04 |
Aminoglycosides
(6,2)
|
|
05.01.05 |
Macrolides
(6,1)
|
|
05.01.06 |
Clindamycin
(2,0)
|
|
05.01.07 |
Some other antibacterials
(3,2)
|
|
|
Chloramphenicol
(1,0)
|
|
|
Fosfomycin
(0,0)
|
|
|
Fusidic acid
(1,0)
|
|
|
Vancomycin and teicoplanin
(3,0)
|
|
|
Daptomycin
(1,0)
|
|
|
Linezolid
(1,0)
|
|
|
Quinupristin and dalfopristin
(0,1)
|
|
|
Polymyxins
(2,0)
|
|
|
Rifaximin
(1,0)
|
|
|
Fidaxomicin
(1,0)
|
|
05.01.08 |
Sulphonamides and trimethoprim
(3,0)
|
|
05.01.09 |
Antituberculosis drugs
(6,9)
|
|
05.01.10 |
Antileprotic drugs
(1,2)
|
|
05.01.11 |
Metronidazole and tinidazole
(2,1)
|
|
05.01.12 |
Quinolones
(7,1)
|
|
05.01.13 |
Urinary-tract infections
(5,0)
|
|
05.02 |
Antifungal drugs
(0,2)
|
|
|
Treatment of fungal infections
(0,0)
|
|
|
Drugs used in fungal infections
(0,2)
|
|
05.02.01 |
Triazole antifungals
(6,0)
|
|
05.02.02 |
Imidazole antifungals
(0,0)
|
|
05.02.03 |
Polyene antifungals
(2,0)
|
|
05.02.04 |
Echinocandin antifungals
(3,0)
|
|
05.02.05 |
Other antifungals
(2,0)
|
|
05.03 |
Antiviral drugs
(0,0)
|
|
05.03.01 |
HIV infection
(1,0)
|
|
|
Nucleoside reverse transcriptase inhibitors
(16,1)
|
|
|
Protease inhibitors
(9,0)
|
|
|
Non-nucleoside reverse transcriptase inhibitors
(4,0)
|
|
|
Other antiretrovirals
(6,1)
|
|
|
Pharmacokinetic enhancers of anti-retrovirals
(0,0)
|
|
|
Combination Products
(0,0)
|
|
05.03.02 |
Herpesvirus infections
(0,1)
|
|
05.03.02.01 |
Herpes simplex and varicella-zoster infection
(4,1)
|
|
05.03.02.02 |
Cytomegalovirus infection
(4,0)
|
|
05.03.03 |
Viral hepatitis
(0,0)
|
|
05.03.03.01 |
Chronic hepatitis B
(3,3)
|
|
05.03.03.02 |
Chronic hepatitis C
(10,4)
|
|
05.03.04 |
Influenza
(4,0)
|
|
05.03.05 |
Respiratory syncytial virus
(2,0)
|
|
05.04 |
Antiprotozoal drugs
(0,0)
|
|
05.04.01 |
Antimalarials
(0,0)
|
|
|
Treatment of malaria
(0,0)
|
|
|
Falciparum malaria (treatment)
(0,0)
|
|
|
Benign malarias (treatment)
(0,0)
|
|
|
Prophylaxis against malaria
(0,0)
|
|
|
Specific recommendations
(0,0)
|
|
|
Artemether with lumefabtrine
(1,0)
|
|
|
Chloroquine
(1,0)
|
|
|
Mefloquine
(1,0)
|
|
|
Primaquine
(1,0)
|
|
|
Proguanil
(1,1)
|
|
|
Pyrimethamine
(1,1)
|
|
|
Quinine
(1,0)
|
|
|
Tetracyclines
(0,0)
|
|
05.04.02 |
Amoebicides
(1,2)
|
|
05.04.03 |
Trichomonacides
(1,0)
|
|
05.04.04 |
Antigiardial drugs
(1,1)
|
|
05.04.05 |
Leishmaniacides
(0,1)
|
|
05.04.06 |
Trypanocides
(0,0)
|
|
05.04.07 |
Drugs for toxoplasmosis
(2,0)
|
|
05.04.08 |
Drugs for pneumocystis pneumonia
(2,0)
|
|
|
Treatment
(0,0)
|
|
|
Prophylaxis
(0,0)
|
|
05.05 |
Anthelmintics
(0,0)
|
|
05.05.01 |
Drugs for threadworms
(2,1)
|
|
05.05.02 |
Ascaricides
(0,0)
|
|
05.05.03 |
Drugs for tapeworm infections
(0,1)
|
|
|
Taenicides
(0,0)
|
|
|
Hydatid disease
(0,0)
|
|
05.05.04 |
Drugs for hookworms
(0,0)
|
|
05.05.05 |
Schistosomicides
(1,0)
|
|
05.05.06 |
Filaricides
(0,0)
|
|
05.05.07 |
Drugs for cutaneous larva migrans
(0,1)
|
|
05.05.08 |
Drugs for strongyloidiasis
(0,0)
|
|
05.06 |
Faecal Microbiota Transplant
(1,0)
|
|
|
|
